Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is yolk sac tumor?
Yolk sac tumor — also called endodermal sinus tumor — is a malignant germ-cell cancer that grows from the body's primitive egg- and sperm-forming cells. It most often arises in the ovary or testicle, but because germ cells travel along the midline early in development, it can also appear in places like the tailbone area (sacrococcygeal), the chest (mediastinum), or the brain. It is most common in infants, children, and young adults. Its signature feature is that it produces a protein called alpha-fetoprotein (AFP) that can be measured in the blood, giving doctors a reliable way to diagnose it, track how well treatment is working, and detect recurrence. Yolk sac tumors tend to grow quickly, but they are very responsive to chemotherapy, so even advanced disease is usually curable. Yolk sac tumor cells are also often part of 'mixed' germ-cell tumors that contain several germ-cell types together.
The main types
Doctors group yolk sac tumor by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Gonadal yolk sac tumor (ovary or testicle) | The most common locations. AFP is almost always elevated and helps guide treatment and follow-up. |
| Extragonadal yolk sac tumor | Arises outside the gonads — for example in the tailbone area, chest, or brain — usually in very young children; treated with surgery and chemotherapy tailored to the site. |
| Mixed germ-cell tumor with a yolk-sac component | Yolk sac tumor combined with other germ-cell types. The yolk-sac part drives the AFP level and a key part of the treatment plan. |
Staging, in plain terms
Because yolk sac tumors arise in different places and ages, staging depends on the site: ovarian tumors use FIGO stages, testicular tumors use TNM with blood markers, and children are staged with the pediatric (Children's Oncology Group) system based on how completely the tumor was removed and whether it has spread. Across systems, the disease is highly curable.
| Site-based staging (ovarian FIGO, testicular TNM, or pediatric COG staging) | What it generally means |
|---|---|
| Localized / completely removed | Tumor confined to its organ of origin and fully removed by surgery. Often cured with surgery, sometimes followed by a short course of chemotherapy. |
| Regional spread | Tumor extends to nearby tissue or lymph nodes, or could not be fully removed. Treated with surgery plus chemotherapy, with excellent cure rates. |
| Metastatic | Spread to distant sites such as the lungs or liver. Still usually curable with platinum-based chemotherapy and surgery for any remaining masses. |
The standard of care
Yolk Sac Tumor is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery
Removing the tumor provides the diagnosis and removes the main mass. For ovarian and testicular tumors this is often fertility-sparing (one ovary and tube, or the affected testicle), with the goal of cure plus preserving future options.
Chemotherapy (platinum-based)
A combination such as bleomycin, etoposide, and cisplatin (BEP) is the backbone for tumors that have spread or were not fully removed, and it cures the great majority of patients.
AFP-guided monitoring
The blood marker AFP is tracked closely. A falling level confirms treatment is working; a later rise can signal recurrence well before symptoms appear.
Surgery for residual masses
If a mass remains after chemotherapy but AFP has normalized, surgeons may remove it to confirm only scar tissue or mature (benign) tissue is left.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while normal cells are better at repairing themselves. For yolk sac tumors, chemotherapy and surgery do nearly all the work, and radiation is rarely needed — which is good news, because most patients are children and young adults whose growing tissues are best protected from radiation. When radiation is used for an unusual resistant spot, it is given as short, painless sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.
The main ways radiation is delivered for yolk sac tumor:
Surgery
The primary local treatment — removes the bulk of the tumor, establishes the diagnosis, and, for early disease, can be curative on its own.
Radiation (rarely used)
Radiation has little routine role in yolk sac tumor because chemotherapy works so well and patients are usually very young, when avoiding radiation protects growing tissues. It is reserved for unusual, treatment-resistant situations.
Palliative radiation
In the uncommon resistant or recurrent case, a short course of targeted radiation can relieve pain or other symptoms from a specific spot.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Risk-adapted chemotherapy: Cooperative-group trials tailor the amount of chemotherapy to risk — giving less to low-risk, fully removed tumors and reserving intensive treatment for higher-risk disease — keeping cure rates high while reducing long-term side effects.[1]
Children's Oncology Group and international germ-cell trials (2020–2025)
AFP as an early warning system: Studies confirm that close AFP monitoring detects recurrence earlier than imaging alone, allowing prompt re-treatment and improving the chance of a second cure.[2]
Germ-cell tumor marker studies (2021–2025)
Reducing late effects in survivors: Efforts to limit bleomycin lung toxicity, hearing loss, and effects on fertility aim to keep the excellent cure rates while improving long-term quality of life for these mostly young survivors.[3]
Survivorship and toxicity-reduction studies (2020–2024)
Common questions
What does the AFP blood test mean for me? Yolk sac tumors make a protein called AFP that shows up in the blood. Your team uses it to confirm the diagnosis, to check that treatment is shrinking the tumor (the level should fall), and to watch for any return of the cancer afterward.
Is this cancer curable? Yes — yolk sac tumor is highly curable. Even when it has spread, the combination of surgery and platinum-based chemotherapy cures the large majority of patients, including most children and young adults.
Will treatment affect fertility? Surgery is often fertility-sparing, removing only the affected ovary and tube or the affected testicle. Chemotherapy can affect fertility, so your team may discuss options such as sperm or egg preservation before treatment begins.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Children's Oncology Group and international germ-cell trials (2020–2025) (no indexed identifier — see your care team) ↩
- Germ-cell tumor marker studies (2021–2025) (no indexed identifier — see your care team) ↩
- Survivorship and toxicity-reduction studies (2020–2024) (no indexed identifier — see your care team) ↩